Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
about
A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersCommentary: Doxasozin for alcoholismStress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.The α1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) Rats.Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence.Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patientsRisk factors for medication non-adherence among psychiatric patients with substance misuse histories.What happens when people discontinue taking medications? Lessons from COMBINE.Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approachDrugs of abuse and HIV infection/replication: implications for mother-fetus transmission.Hepatitis infection in the treatment of opioid dependence and abuse.Adherence with general healthcare among internal medicine outpatients with mental health treatment histories.Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humansA randomized trial evaluating an mHealth system to monitor and enhance adherence to pharmacotherapy for alcohol use disorders.Factors associated with medication adherence among psychiatric outpatients at substance abuse risk.Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilizationComparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder.Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment responseMedication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.Relationship between medication adherence and treatment outcomes: the COMBINE study.Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.Socioeconomic disparities in access to a hepatocellular carcinoma screening program in Brazil.Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization.Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.Review: alcohol use and problems among immigrants from the former Soviet Union in Israel.Causal considerations on alcohol and HIV/AIDS--a systematic review.HIV and risk behaviors of persons of low socio-economic status, Popayan-Colombia (2008-2009).The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.Disparities in pharmacotherapy for alcohol use disorder in the context of universal health care: a Swedish register study.Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial.Daily relations among affect, urge, targeted naltrexone, and alcohol use in young adults.Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice.Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey.A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependencPerceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment.Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial.
P2860
Q27000732-A3909774-B2C2-4A9E-BDDA-2A5A30136309Q28831204-CDB2E2A2-5845-40B4-AD1F-8617D9C93C5EQ30366964-A89666F0-9EAD-4E78-AD91-C124228C0D4DQ30443459-FFBF3414-4EBD-497C-8A94-B04DF6DEF9E0Q33704889-88694F98-8059-446C-AA02-DDBA8B9D92E9Q33949899-2910858F-AF48-4ACA-94FC-363D10281EEBQ34291872-83733A34-A043-4179-BCDB-6F818C9BBE0CQ34314633-15258613-1AF0-4B05-8F22-92EA95AE1882Q34626269-DCC3F658-2285-47AE-8A29-0B79931D1725Q34767177-F08F47EB-1A34-454E-A79E-A1F28F8B671BQ35000656-64E0B08A-5688-4141-9F15-93232E0B42DBQ35389163-C5B36B7E-FD85-4752-9836-CAEA775EC758Q35570854-AF9D94E3-E820-4DA3-90C9-1A7CDD942965Q36338815-37036F9F-1BD0-4C91-A9B9-A1FB6F92D8B2Q36426978-90DC0246-1922-458F-B52F-9CE5C662EE92Q36477203-9A8D434C-B042-449E-A42E-75459C940B89Q36567472-EEC5B672-9152-48BA-8249-34B0308D93F9Q36635305-8659BC3F-4536-4BA2-8FD7-0B84D2385392Q36677871-B8EA156A-3DB4-46A7-83E9-2F5965281D53Q36872397-CBBCA054-89B2-4C64-AEBD-CE2E81D471BEQ36952204-E0AA154B-1939-4660-9F69-78B7F3340FACQ37082551-32E3E57B-F71A-4E7E-9AC0-C07A8DB65E9BQ37097854-A3F2744E-4FE5-4B25-B637-061018E547A1Q37120185-C6C4004C-17D3-457E-A8C2-FADF3CF29CECQ37276159-4FEDCC8F-0AD1-4D0B-9D4D-8C60A70DA6A8Q37337678-1B4717CC-6CD4-4755-A6B8-9C3CCD32992DQ37671424-56A93974-BA97-4475-ADE7-65C3C0F7FA97Q37727474-D4A3791B-6B8A-4155-BBB9-03786A7A73CCQ38801718-C382066C-25C6-4361-9CC9-212D78B3BAABQ38838575-28731536-C2F6-45ED-A529-193946EA7AE3Q38871336-0B11EE9D-C943-4DD6-8394-27DE6FD8C875Q39333954-953D49C3-B195-4267-B0E4-FF595B56D2D9Q42001372-29795103-7C38-4C05-924F-C84CE9712385Q43751280-FC28335F-7A23-4386-BB27-969CF4A7A0ECQ44345855-09123B93-A03D-4946-9818-F26BFDFC70E4Q45384257-52F657C6-2E23-4884-AE04-B0476992E086Q46765992-BA9FE001-E522-4C42-BF5D-055C1F105F21Q50927123-22CD20B7-6902-4E46-A392-CF5A8A8F79EA
P2860
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
@ast
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
@en
type
label
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
@ast
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
@en
prefLabel
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
@ast
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
@en
P2860
P1433
P1476
Adherence to pharmacotherapy in patients with alcohol and opioid dependence.
@en
P2093
Roger D Weiss
P2860
P304
P356
10.1111/J.1360-0443.2004.00884.X
P407
P577
2004-11-01T00:00:00Z